Oh. Well, that was an unusual beginning to this post: You didn’t know the CDC has a patent on a newer and different strain of the Ebola virus that is rampaging unchecked in Africa? Well, they do. As to why, ask yourself if it’s for the same reason others get patents on inventions and innovations. The answer is ‘probably.’
I have no idea what right-minded adult doesn’t get a little shaky when hearing about the fast-acting, devastating impact the Ebola virus had across a portion of the world during the last epidemic, also in Africa, the last time. Now, envision that death toll increased by a minimum factor of ten. It’s a disease that we ordinary citizens here have been fortunate enough to avoid.
But Obummer was oh, so wise in his usual judgment that he’s already allowed it into the country. Two suffers were transported through Atlanta, Georgia where the Center for Disease Control is hosted. As the first arrivals or Ebola patients now in this country, the containment procedures may — may — have been a little rusty. Practice makes perfect, right?
Will that CDC-held patent be of any help to these or future cases? Unfortunately not. The strains are not identical. Any adjustment in the life cycle, stages or physical structure of the virus determine they are not the same ones, and like the flu virus, there are different strains that cannot be treated successfully with the cure for different kinds.
But why would the CDC apply for and obtain patent no. CA2741523A1 and its ‘nicknamed’ tag, Ecobun,’ awarded in 2010? They got one to control the vaccine development and retain the commercial rights to sell the pandemic’s solution, when — not if — the Ecobun epidemic should break out one day.
Personally, I’ve no doubt whatsoever that the government continues to experiment on a valid vaccine as they do for the strain invading the African continent. What do organizations owning patents do to recoup expenses and try for a profit?
If you control a patent, you control who can further develop “offshoot” programs, including vaccines, its purchase cost per dose and who can buy it. You have governmental protection for 20 years on inventions, which equates to 20 years of commercial moneys possible from it. If this disease invention was only for humanitarian goals and motives, why not leave it patent-free and let everyone combine strength and talents the planet of outbreak threats of this horrible disease?
Oh. Those two newly arrived patients? While undergoing treatment in Atlanta, they’re close at hand for basic strain harvesting and vaccine experimentation, aren’t they? Isn’t that convenient…